PF3D7_1356300 encodes the SUMO E2-conjugating enzyme (Ubc9) of Plasmodium falciparum, functioning within the parasite SUMOylation pathway (PMID:26697886). X-ray crystallography of the human SUMO E1–E2 complex combined with in silico modeling, mutagenesis, and in vitro biochemistry of the P. falciparum SUMO E1 and E2 enzymes established that the P. falciparum E1–E2 interface is distinct from its human counterpart, defining a parasite-specific E1–E2 interaction mechanism (PMID:26697886). Interaction specificity extends to the SUMO substrate: Pf-SUMO can engage human Ubc9, but human SUMO1 fails to interact with Pf-E2, and critical N-terminal residues of Pf-E2 are responsible for this diminished cross-species interaction, since mutating them to the corresponding human residues restores binding (PMID:35331687). Perturbation of SUMOylation, which requires E2/Ubc9, sensitizes trophozoite-stage parasites to iron-induced oxidative stress, indicating a protective role for the pathway during intraerythrocytic development (PMID:26697886). Beyond these species-specificity determinants and the oxidative-stress phenotype, the substrate repertoire and broader regulatory functions of PF3D7_1356300 have not been characterized in the available corpus.